Abstract: Health systems built under resource constraints have often developed radically efficient ways to deliver care. As similar constraints emerge in the U.S., these models reveal a broader opportunity. Our hypothesis is that making clinical repair more standardized, efficient, and reliable can change the economics of healthcare, freeing scarce resources and increasing the opportunity cost of continuing to allocate them to repair. That capacity can move upstream into prevention, public health, and everyday healthy living. The opportunity is not simply to make healthcare cheaper. It is to change what healthcare makes economically possible and to create new markets around better everyday health.

The back story

In June, Fairbridge partnered with FedCap Group and its new Chief Medical Officer Dr. Jay Varma to host a Reshoring Health Innovation mini-summit at Civic Hall at Union Square. We convened a group of clinical operators, public health veterans, founders, and investors to identify global health innovations with the greatest potential to be adapted and scaled to serve low- and middle-income Americans.

The premise was straightforward: the U.S. has spent decades and billions of dollars developing health solutions in resource-constrained environments around the world. It is time to repatriate that knowledge and capture the innovation dividend here at home.

We expected to leave with a list of interesting public health ideas that could be brought back to the United States. Instead, our keynote left us with something more profound. Viren Shetty explained how a relentless focus on throughput and utilization has helped Narayana Health drive down the cost of complex cardiac surgery and other interventions while maintaining strong outcomes. This focus has made Narayana one of the most efficient clinical repair systems in the world.

That observation became the starting point for a much broader question: What happens when we apply the same logic to the healthcare system itself?

Foundational systems that generate high-value public goods have traditionally been left to governments, non-profits, and development agencies because their benefits are diffuse and difficult to translate into billable products and services. But technological acceleration and growing system strain are changing the conditions under which these markets can be built.

Healthcare is a particularly powerful example. Prevention can generate enormous global economic return, but that return is often diffuse. Meanwhile return from clinical repair is easier for individual providers, companies, and investors to capture. As a result, talent, capital, and innovation have naturally flowed toward repair, even when the broader return to prevention may be greater. The opportunity is to change that equation.

When repair becomes more standardized, efficient, and reliable, its cost falls and its excess economic returns compress. The opportunity cost of continuing to allocate scarce talent, capital, and attention to repair rises, creating room for those resources to move toward prevention and other higher-value use cases.

The goal is not to choose prevention over repair. It is to make the system more productive at repair so that more of its scarce capacity can be directed toward keeping people healthy in the first place.

Resource constraint → standardization → reliability → released capacity → higher-value innovation → better public health

Where Pathways are forming

At Fairbridge, we look at all market opportunities through a lens of access. In healthcare, we see several emerging pathways where the conditions for upstream market formation are beginning to emerge.

These examples are different on the surface. Underneath, they point toward a common possibility: use constraint, coordination, technology, and better economic design to make essential health capabilities more accessible and scalable.

This has been addressed before in other industries

Some of the most reliable industries in the world have learned to solve a problem healthcare still struggles with: how to make essential capabilities both highly reliable and economically accessible.

Defense is a useful comparison. National security requires capabilities that would be prohibitively expensive if every institution had to develop and purchase them independently. Coordinated procurement, standardized requirements, long-term contracts, and shared infrastructure aggregate demand and create the economics to produce sophisticated capabilities at scale. The customer benefits not only from reliability, but from the lower cost that comes with coordinated demand.

Healthcare on the other hand has far fewer of these mechanisms. Purchasing is fragmented across hospitals, insurers, employers, and individuals. Even when institutions are buying essentially the same underlying products or services, they often negotiate and operate independently. The result is a paradox: healthcare is one of the largest markets in the world, yet its fragmentation can prevent the scale economics that would make many essential capabilities cheaper for everyone. The opportunity, then, is not simply to make healthcare more reliable. It is to build the coordination, standardization, and procurement mechanisms that allow reliability and affordability to reinforce each other.

We started this conversation with the goal of applying proven and tested models from other places back home, and our ambition is broadening.

So why does this matter today?

The economic consequences of poor health are already enormous, driven by chronic disease, lost productivity, and the departure of unpaid caregivers from the formal labor market. At the same time, technology is making it possible to measure health continuously, deliver expertise at lower cost, automate parts of care, and coordinate interventions across populations.

The opportunity is therefore bigger than making healthcare cheaper. It is to make prevention economically durable. If we can connect more efficient clinical repair with better economic design, technology, and new models of population health, we can begin to capture a share of the enormous economic value associated with healthier populations, while building businesses capable of scaling that value. Improving population health need not remain a philanthropic cost center. It can become a source of productivity, resilience, and commercial value.

Where Fairbridge is looking for opportunity

This is a space we are spending real time in. The Coordinated Health Alliance is our working thesis for how new markets in prevention and public health can form. Within healthcare, we are particularly interested in where continuous data, scalable intelligence, coordinated demand, aligned payment, and lower-cost delivery are beginning to converge.

That includes companies standardizing clinical repair so that capacity can move upstream; building continuous-care and community models that keep people healthier and out of the hospital; developing public-health infrastructure that can first be sold to commercial buyers; and creating new ways to deliver care with less labor per patient.

If you have found the transaction that turns a healthcare access gap into a business someone pays for, and can show us why it scales, we want to hear from you.

Join our Mission

Please share this post with builders, investors, catalysts, and policy people in your networks!

Here is a two-page brief on the Coordinated Health Alliance Research we published at Fairrbridge. If you then would like to read the full paper, or would like to collaborate on this topic you can reach out to us at [email protected].

And if you are a founder, you can apply for funding.

And thanks to our sponsor this week: Hubspot!

This guide distills 10 AI strategies from industry leaders that are transforming marketing.

Outpace your competitors by mastering AI.

Get Your Free Guide